Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Proteros Biostructures GmbH. (12/9/11). "Press Release: Proteros Expands Business Development Acitivites in Japan in Response to Growth Opportunities". Martinsried.

Organisations Organisation Proteros Biostructures GmbH
  Group Proteros (Group)
  Organisation 2 BizCom Japan Inc.
Products Product X-ray crystallography
  Product 2 compound profiling
Persons Person D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America)
  Person 2 Usui, Akira (Ray Life Sciences 2007– President + founder before Perlegen Japan + Roche Japan + Tanabe Seiyaku)
     


Proteros biostructures GmbH ("Proteros") has been active in Japan for over four years and is pleased to announce the expansion of its business development activities. In addition to CTC Laboratory Systems Corporation, wholly owned subsidiary of the Itochu corporation (CTCLS) Proteros will be supported by BizCom Japan Inc. (BizCom) and Ray Life Sciences Inc. (RLS).

CTCLS will continue to support Proteros' X-ray crystallography analysis services through its extensive direct sales network and offices in Tokyo and Osaka. BizCom will use its expertise in biophysics to promote Proteros' kinetic and thermodynamic profiling services as well as Proteros' Custom Proteins service. RLS is headed by Akira Usui, who has an extensive background in pharma licensing and corporate development. RLS will provide business development support for Proteros' integrated Lead Discovery service where targets are nominated by clients or lead compounds are generated by Proteros.

CTCLS, BizCom and RLS will further facilitate interactions with clients in Japan. Proteros will continue to assist through close interaction and direct communication as is required by the complexity and technical nature of the projects.

"Proteros has established a number of very productive collaborations with major Japanese pharmaceutical companies over the past four years. We believe that this expansion of our business development activities will enable Proteros to offer an increased level of service to our Japanese clients" said Cony D'Cruz, Chief Business Officer, Proteros.


About Proteros biostructures GmbH:

Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. The company accelerates and improves protein structure analysis and structure-based drug discovery with its expertise, industrialized processes and unique technologies for crystallography and fragment-based lead generation. Proteros complements its clients' internal capabilities with external expertise and access to flexible resources. Proteros currently provides services for more than 60 pharmaceutical and biotechnology clients in North America, Europe and Asia.

Contact:

Proteros biostructures GmbH
Thomas Waldmann, Ph.D.
Proteros Biostructures GmbH
Bunsenstrasse 7a
D-82152 Planegg-Martinsried
Germany
Phone: +49 (0) 89 7007 61 - 0
Fax: +49 (0) 89 7007 61 - 15
E-Mail: waldmann@proteros.com
Internet: www.proteros.com

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Proteros (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top